Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation
Per Svensson, Robin Hofmann, Henrike Häbel, Tomas Jernberg, Per Nordberg, Per Svensson, Robin Hofmann, Henrike Häbel, Tomas Jernberg, Per Nordberg
Abstract
Aims: The risks associated with diabetes, obesity and hypertension for severe COVID-19 may be confounded and differ by sociodemographic background. We assessed the risks associated with cardiometabolic factors for severe COVID-19 when accounting for socioeconomic factors and in subgroups by age, sex and region of birth.
Methods and results: In this nationwide case-control study, 1.086 patients admitted to intensive care with COVID-19 requiring mechanical ventilation (cases), and 10.860 population-based controls matched for age, sex and district of residency were included from mandatory national registries. ORs with 95% CIs for associations between severe COVID-19 and exposures with adjustment for confounders were estimated using logistic regression. The median age was 62 years (IQR 52-70), and 3003 (24.9%) were women. Type 2 diabetes (OR, 2.3 (95% CI 1.9 to 2.7)), hypertension (OR, 1.7 (95% CI 1.5 to 2.0)), obesity (OR, 3.1 (95% CI 2.4 to 4.0)) and chronic kidney disease (OR, 2.5 (95% CI 1.7 to 3.7)) were all associated with severe COVID-19. In the younger subgroup (below 57 years), ORs were significantly higher for all cardiometabolic risk factors. The risk associated with type 2 diabetes was higher in women (p=0.001) and in patients with a region of birth outside European Union(EU) (p=0.004).
Conclusion: Diabetes, obesity and hypertension were all independently associated with severe COVID-19 with stronger associations in the younger population. Type 2 diabetes implied a greater risk among women and in non-EU immigrants. These findings, originating from high-quality Swedish registries, may be important to direct preventive measures such as vaccination to susceptible patient groups.
Trial registration number: Clinicaltrial.gov (NCT04426084).
Keywords: COVID-19; diabetes & endocrinology; hypertension; intensive & critical care.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
References
- Williamson EJ, Walker AJ, Bhaskaran K, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430–6. 10.1038/s41586-020-2521-4
- Barron E, Bakhai C, Kar P, et al. . Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol 2020;8:813–22. 10.1016/S2213-8587(20)30272-2
- Stefan N, Birkenfeld AL, Schulze MB, et al. . Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol 2020;16:341–2. 10.1038/s41574-020-0364-6
- Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. 10.1016/S0140-6736(20)30566-3
- Mancia G, Rea F, Ludergnani M, et al. . Renin–Angiotensin–Aldosterone system blockers and the risk of Covid-19. N Engl J Med Overseas Ed 2020;382:2431–40. 10.1056/NEJMoa2006923
- Fosbøl EL, Butt JH, Østergaard L, et al. . Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. JAMA 2020;324:168. 10.1001/jama.2020.11301
- Petrilli CM, Jones SA, Yang J, et al. . Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020;369:m1966. 10.1136/bmj.m1966
- Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation 2020;142:4–6. 10.1161/CIRCULATIONAHA.120.047659
- Stefan N, Causes SN. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol 2020;8:616–27. 10.1016/S2213-8587(20)30110-8
- Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 2020;50:54–67. 10.1007/s11239-020-02134-3
- Pareek M, Bangash MN, Pareek N, et al. . Ethnicity and COVID-19: an urgent public health research priority. Lancet 2020;395:1421–2. 10.1016/S0140-6736(20)30922-3
- Bornstein SR, Rubino F, Khunti K, et al. . Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020;8:546–50. 10.1016/S2213-8587(20)30152-2
- Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19 - Studies Needed. N Engl J Med 2020;382:1194–6. 10.1056/NEJMp2002125
- Holman N, Knighton P, Kar P, et al. . Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 2020;8:823–33. 10.1016/S2213-8587(20)30271-0
- Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. . The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659–67. 10.1007/s10654-009-9350-y
- Swedish registry for Intensive Care . National quality Registry for intensive care.. Available:
- Ludvigsson JF, Andersson E, Ekbom A, et al. . External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450. 10.1186/1471-2458-11-450
- Ludvigsson JF, Svedberg P, Olén O, et al. . The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol 2019;34:423–37. 10.1007/s10654-019-00511-8
- Oras P, Häbel H, Skoglund PH, et al. . Elevated blood pressure in the emergency department: a risk factor for incident cardiovascular disease. Hypertension 2020;75:229–36. 10.1161/HYPERTENSIONAHA.119.14002
- Wang D, Hu B, Hu C, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061–9. 10.1001/jama.2020.1585
- Grasselli G, Zangrillo A, Zanella A, et al. . Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020;323:1574–81. 10.1001/jama.2020.5394
- Torpy JM, Lynm C, Glass RM. The metabolic syndrome. JAMA 2006;295:850.10.1001/jama.295.7.850
- Schultz WM, Kelli HM, Lisko JC, et al. . Socioeconomic status and cardiovascular outcomes. Circulation 2018;137:2166–78. 10.1161/CIRCULATIONAHA.117.029652
- Gao C, Cai Y, Zhang K, et al. . Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J 2020;41:2058–66. 10.1093/eurheartj/ehaa433
- Kreutz R, Algharably EAE-H, Azizi M, et al. . Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res 2020;116:1688–99. 10.1093/cvr/cvaa097
- Tziomalos K, Athyros VG, Karagiannis A, et al. . Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutr Metab Cardiovasc Dis 2010;20:140–6. 10.1016/j.numecd.2009.08.006
- Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–7. 10.1038/nature05485
- Drummond GR, Vinh A, Guzik TJ, et al. . Immune mechanisms of hypertension. Nat Rev Immunol 2019;19:517–32. 10.1038/s41577-019-0160-5
- Loperena R, Van Beusecum JP, Itani HA, et al. . Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide. Cardiovasc Res 2018;114:1547–63. 10.1093/cvr/cvy112
- Siedlinski M, Jozefczuk E, Xu X, et al. . White blood cells and blood pressure: a Mendelian randomization study. Circulation 2020;141:1307–17. 10.1161/CIRCULATIONAHA.119.045102
- Pons S, Fodil S, Azoulay E, et al. . The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care 2020;24:353. 10.1186/s13054-020-03062-7
- Price-Haywood EG, Burton J, Fort D, et al. . Hospitalization and mortality among black patients and white patients with Covid-19. New England Journal of Medicine 2020;382:2534–43. 10.1056/NEJMsa2011686
- Lassale C, Gaye B, Hamer M, et al. . Ethnic disparities in hospitalisation for COVID-19 in England: the role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study. Brain Behav Immun 2020;88:44–9. 10.1016/j.bbi.2020.05.074
- Rhodes A, Ferdinande P, Flaatten H, et al. . The variability of critical care bed numbers in Europe. Intensive Care Med 2012;38:1647–53. 10.1007/s00134-012-2627-8
Source: PubMed